ArticleBreast cancer research and treatment2026
Implementation and evaluation of the Routine Assessment and Integration of Screening for Employment (RAISE) program in adults with metastatic breast cancer.
Article in Breast cancer research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAdults living with metastatic breast cancer (mBC) often have unmet employed-related needs. To address this gap, we developed, implemented, and evaluated the Routine Assessment and Integration of Screening for Employment (RAISE) program for adults with mBC.
methodsWe designed a quality improvement project informed by the Specific, Measurable, Attainable, Relevant, and Timebound framework. In Phase 1 (development), we built and integrated an English/Spanish screener into the electronic health record (EHR) platform. In Phase 2 (implementation), 48 h before an oncology visit, patients received alerts through the patient portal that a screening assessment was available. Patients who reported needing support for employment-related concerns triggered an EHR alert to a patient navigator who reached out to offer educational resources (physical booklet and/or mobile app). Phase 3 (evaluation) was guided by the RE-AIM framework and included surveys and interviews with patients, providers, and staff to evaluate acceptability and feasibility of RAISE.
resultsBetween March 2024 and August 2025, 179 patients with mBC completed the RAISE screener Of these, 22 (22/179, 12.2%) requested assistance/navigation and were provided with educational resources. Among 41 (41/179, 23%) patients surveyed (evaluation phase), 33 patients had completed the screener, and 8 had not. Of those who completed the screener and the evaluation survey, 91% (29/33) reported they were somewhat or very satisfied with RAISE and 78% (25/33) reported the EHR screening questions were clear to them. Key themes that emerged from 5 patient and 10 provider interviews included utility of the resources offered, screening preferences, and barriers to incorporation of screening into the clinical workflow.
conclusionsScreening for unmet employment needs and delivering resources and navigation is preliminarily feasible and acceptable to patients with mBC, providers, and staff at two NYC hospitals, though key barriers to implementation exist, including low pre-visit screening uptake and integration into the clinical workflow. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.